TherapeuticsMD, Inc. (TXMD) Stock

Healthcare · Drug Manufacturers - Specialty & Generic · Member of Other US Stocks

TherapeuticsMD, Inc. (TXMD) closed at USD 1.97 on 2026-10-14, a change of +57.6 % over the past year, with a market capitalization of USD 22.34M.

TherapeuticsMD, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

TherapeuticsMD, Inc. key figures

Previous close

USD 1.97 (2026-10-14)

1-year change

+57.6 %

Market cap

USD 22.34M

Enterprise value

USD 18.71M

P/E ratio (trailing)

-48.25

P/E ratio (forward)

5.51

EPS (trailing)

-0.04

EPS (forward)

0.35

PEG ratio

n/a

Price to book

0.82

Revenue growth

-8.7 %

Earnings growth

-80.6 %

Dividend per share (trailing)

0.00

Short ratio

1.15

Employees

1

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About TherapeuticsMD, Inc.

TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States and internationally. Its products portfolio includes IMVEXXY for the treatment of moderate-to-severe dyspareunia, a symptom of vulvar and vaginal atrophy due to menopause; BIJUVA to treat moderate-to-severe vasomotor symptoms due to menopause in women with a uterus; and ANNOVERA, a ring-shaped contraceptive vaginal system. The company also offers prescription prenatal vitamin products under the BocaGreenMD and vitaMedMD brand names. It has a license agreement with Mayne Pharma Group Limited. The company sells its products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for TherapeuticsMD, Inc. and compare it with other stocks.